Top News
Home >> Top news >> Leica rolls out next-gen research stainer

Leica rolls out next-gen research stainer

Print Friendly, PDF & Email

July 26, 2018Leica Biosystems introduced the Bond Rx next-generation research stainer. The new system offers greater flexibility when optimizing conditions for a variety of test types including immunofluorescence, immunohistochemistry, fluorescence in situ hybridization, tyramide signal amplification, multiplexing, and other emerging tests.

Bond Rx allows users to customize dewax options, choose from six probe application and removal protocols, and select the dispense type from three reagent flow options. Reagents are illuminated and provide clear visual alerts, and the version 6.0 software features a highly visual user interface with easy to identify iconography.

“With science advancing at such a rapid rate, it is an exciting time to be supporting researchers as they seek to unlock the complexity of cancer biology and develop new approaches to diagnosis,” Colin White, PhD, global VP of advanced staining, Leica Biosystems, said in a press release. “The release of the next generation of Bond Rx is an important milestone in providing our customers with broader experimental flexibility and improved usability.”

More top news


Check Also

Digital pathology scanner, 5/16

May 2016—Leica Biosystems introduced the Aperio Versa, a combination digital pathology research scanner for bright-field, fluorescence, and FISH imaging. High levels of automation and an optional 200-slide autoloader enable unsupervised batch processing, from low magnification to high resolution, oil-immersion scanning.